BDNF ATTENUATES THE EFFECTS OF INTRASTRIATAL INJECTION OF 6-HYDROXYDOPAMINE

被引:85
|
作者
SHULTS, CW
KIMBER, T
ALTAR, CA
机构
[1] UNIV CALIF SAN DIEGO,DEPT NEUROSCI,LA JOLLA,CA 92093
[2] REGENERON PHARMACEUT INC,TARRYTOWN,NY 10591
关键词
BRAIN-DERIVED NEUROTROPHIC FACTOR; PARKINSONS DISEASE; 6-HYDROXYDOPAMINE; STRIATUM; DOPAMINE; SUBSTANTIA NIGRA; NEUROPROTECTION; NEUROTROPHIN;
D O I
10.1097/00001756-199505300-00009
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
GROUPS of eight rats received unilateral, intrastriatal injections of 22.5 mu g brain-derived neurotrophic factor (BDNF)or cytochrome c on 3 consecutive days. Following the injection of BDNF or cytochrome c on the second day, each animal received an intrastriatal injection of 25 mu g of C-hydroxydopamine (6-OHDA). During the second week following treatment and thereafter, the animals that received BDNF had significantly fewer apomorphine-induced, contraversive rotations than did the animals that received cytochrome c. The animals that received BDNF but not those that received cytochrome c had a halo of dopaminergic axons around the injection site. Our data indicate that BDNF can attenuate the loss of dopaminergic axons and rotational asymmetry that result from an intrastriatal injection of 6-OHDA.
引用
收藏
页码:1109 / 1112
页数:4
相关论文
共 50 条
  • [1] Intrastriatal injection of GDNF attenuates the effects of 6-hydroxydopamine
    Shults, CW
    Kimber, T
    Martin, D
    [J]. NEUROREPORT, 1996, 7 (02) : 627 - 631
  • [2] PARTIAL BEHAVIORAL RECOVERY FOLLOWING INTRASTRIATAL 6-HYDROXYDOPAMINE INJECTION
    LEAVITT, ML
    KLINE, K
    DEVENYI, C
    MAROON, JC
    [J]. FASEB JOURNAL, 1994, 8 (05): : A892 - A892
  • [3] Excessive expression of ezrin in the hippocampus is induced by intrastriatal injection of 6-hydroxydopamine
    Inden, Masatoshi
    Matsumoto, Yosuke
    Asano, Shinji
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2014, 124 : 211P - 211P
  • [4] Excessive Expression of Hippocampal Ezrin Is Induced by Intrastriatal Injection of 6-Hydroxydopamine
    Matsumoto, Yosuke
    Murakami, Hiroki
    Hattori, Naoki
    Yoshimoto, Kanji
    Asano, Shinji
    Inden, Masatoshi
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2011, 34 (11) : 1753 - 1758
  • [5] VITAMIN-E ATTENUATES THE TOXIC EFFECTS OF INTRASTRIATAL INJECTION OF 6-HYDROXYDOPAMINE (6-OHDA) IN RATS - BEHAVIORAL AND BIOCHEMICAL-EVIDENCE
    CADET, JL
    KATZ, M
    JACKSONLEWIS, V
    FAHN, S
    [J]. BRAIN RESEARCH, 1989, 476 (01) : 10 - 15
  • [6] Changes in cytokine levels following an intrastriatal injection of 6-hydroxydopamine to the rat.
    Earl, CD
    Pitossi, F
    Kaczmarczyk, E
    Del Rey, A
    Besedovsky, H
    Oertel, WH
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 1998, 10 : 200 - 200
  • [7] RETROGRADE DEGENERATION OF NIGROSTRIATAL NEURONS INDUCED BY INTRASTRIATAL 6-HYDROXYDOPAMINE INJECTION IN RATS
    BERGER, K
    PRZEDBORSKI, S
    CADET, JL
    [J]. BRAIN RESEARCH BULLETIN, 1991, 26 (02) : 301 - 307
  • [8] Intrastriatal injection of 6-hydroxydopamine does not induce lipid peroxidation in the rat: Histochemical analysis
    Warren, DL
    Zeng, BY
    Jenner, P
    Halliwell, B
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1996, 119 : P279 - P279
  • [9] IMPAIRMENT OF AVOIDANCE PERFORMANCE BY INTRASTRIATAL ADMINISTRATION OF 6-HYDROXYDOPAMINE
    NEILL, DB
    BOGGAN, WO
    GROSSMAN, SP
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1974, 2 (01) : 97 - 103
  • [10] DOSE-DEPENDENT LESIONS OF THE DOPAMINERGIC NIGROSTRIATAL PATHWAY INDUCED BY INTRASTRIATAL INJECTION OF 6-HYDROXYDOPAMINE
    PRZEDBORSKI, S
    LEVIVIER, M
    JIANG, H
    FERREIRA, M
    JACKSONLEWIS, V
    DONALDSON, D
    TOGASAKI, DM
    [J]. NEUROSCIENCE, 1995, 67 (03) : 631 - 647